Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/04/2014US8642799 Cysteine protease inhibitors for the treatment of parasitic diseases
02/04/2014US8642779 Compositions useful as inhibitors of protein kinases
02/04/2014US8642776 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
02/04/2014US8642775 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
02/04/2014US8642773 P38MAP kinase inhibitor
02/04/2014US8642772 Piperidine compounds, pharmaceutical composition comprising the same and its use
02/04/2014US8642770 Indole derivative
02/04/2014US8642768 Dimethyl-benzoic acid compounds
02/04/2014US8642761 Method for producing 3-amidinophenylalanine derivatives
02/04/2014US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/04/2014US8642756 Nucleoside phosphoramidates
02/04/2014US8642666 Biodegradable block copolymeric compositions for drug delivery
02/04/2014US8642662 Methods of using derivatives of (−)-venlafaxine
02/04/2014US8642661 Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists
02/04/2014US8642660 Method for altering the lifespan of eukaryotic organisms
02/04/2014US8642659 Hair treatment product and hair after-treatment product containing ether guanidines as active substances, for protecting from damage caused by chemical treatment and for repairing already damaged hair
02/04/2014US8642658 Treatment of neural diseases or conditions
02/04/2014US8642657 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
02/04/2014US8642656 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
02/04/2014US8642655 Systems and methods for preventing cancer and treating skin lesions
02/04/2014US8642654 Hydroxybutyrate ester and medical use thereof
02/04/2014US8642653 Ketone compounds and compositions for cholesterol management and related uses
02/04/2014US8642652 Cosmetic compositions containing esters based on 2-propylheptanol
02/04/2014US8642651 Methods and compositions for improved chromium complexes
02/04/2014US8642650 Methods of treating an overweight or obese subject
02/04/2014US8642649 Orally dispersible tablet
02/04/2014US8642648 Orally dispersible tablet
02/04/2014US8642647 N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
02/04/2014US8642646 Method and composition for treating acne using lignan compounds
02/04/2014US8642645 Pharmaceutical composition comprising Cannabinoids
02/04/2014US8642643 CXCR2 antagonists
02/04/2014US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
02/04/2014US8642641 Co-crystals of pyrrolidinones
02/04/2014US8642640 1-phenylpyrrole derivatives
02/04/2014US8642639 Formulation for L-tryptophane comprising carbidopa/benserazide
02/04/2014US8642638 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
02/04/2014US8642637 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
02/04/2014US8642635 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
02/04/2014US8642634 Fungicidal azocyclic amides
02/04/2014US8642633 Di-substituted amides for enhancing glutamatergic synaptic responses
02/04/2014US8642632 Selective androgen receptor modulators
02/04/2014US8642631 Methods of treating mammals with eustachian tube dysfunctions
02/04/2014US8642630 Endogeneous repair factor production accelerators
02/04/2014US8642629 Naphthylacetic acids
02/04/2014US8642628 Pyrrole inhibitors of S-nitrosoglutathione reductase
02/04/2014US8642627 Formulation and use thereof
02/04/2014US8642626 Ethinyl-pyrazole derivative
02/04/2014US8642625 Therapeutic agent or preventive agent for urine collection disorder
02/04/2014US8642624 Substituted alkylamine derivatives and methods of use
02/04/2014US8642623 Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
02/04/2014US8642622 Piperidinyl compound as a modulator of chemokine receptor activity
02/04/2014US8642621 (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
02/04/2014US8642620 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
02/04/2014US8642619 Quinolone compound and pharmaceutical composition
02/04/2014US8642618 Carbostyril derivatives including cilostazol for treating fatty liver
02/04/2014US8642617 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
02/04/2014US8642616 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
02/04/2014US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
02/04/2014US8642614 Toll-like receptor modulators and uses thereof
02/04/2014US8642613 Treatment for leukemia and idiopathic aplastic anemia
02/04/2014US8642612 Nicotinic desensitizers and methods of selecting, testing, and using them
02/04/2014US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
02/04/2014US8642610 Dual small molecule inhibitors of cancer and angiogenesis
02/04/2014US8642609 Modulators of ATP-binding cassette transporters
02/04/2014US8642608 Quinazoline derivatives as VEGF inhibitors
02/04/2014US8642607 4H-chromen-4-one compounds as modulators of protein kinases
02/04/2014US8642606 ZAP-70 active compounds
02/04/2014US8642605 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
02/04/2014US8642604 Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents
02/04/2014US8642603 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
02/04/2014US8642602 Method of inhibiting fibrogenesis and treating fibrotic disease
02/04/2014US8642601 Inhibitors of JNK
02/04/2014US8642600 Method of treating autism
02/04/2014US8642599 Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
02/04/2014US8642598 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
02/04/2014US8642597 Pyrazole compounds for controlling invertebrate pests
02/04/2014US8642596 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
02/04/2014US8642595 Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof
02/04/2014US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors
02/04/2014US8642593 2,4-pyrimidinediamine compounds and prodrugs and their uses
02/04/2014US8642592 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
02/04/2014US8642591 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament
02/04/2014US8642590 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
02/04/2014US8642588 Short-acting benzodiazepine salts and their polymorphic forms
02/04/2014US8642586 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
02/04/2014US8642585 Indanyloxydihydrobenzofuranylacetic acids
02/04/2014US8642584 Method of using PI3K and MEK modulators
02/04/2014US8642583 Serotonin receptor modulators
02/04/2014US8642582 Morpholinone compounds as factor IXa inhibitors
02/04/2014US8642581 Compositions and methods for the production of S-adenosylmethionine within the body
02/04/2014US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives
02/04/2014US8642579 1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
02/04/2014US8642578 Elastin protective polyphenolics and methods of using the same
02/04/2014US8642577 Compounds, compositions and methods for the treatment of poxvirus infections
02/04/2014US8642576 Heterocyclic CETP inhibitors
02/04/2014US8642575 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof
02/04/2014US8642574 Surgical compositions for reducing the incidence of adhesions
02/04/2014US8642573 Methods of treating hepatic encephalopathy
02/04/2014US8642572 Cytidine derivative-containing antitumor agent for continuous intravenous administration
02/04/2014US8642568 Method of diagnosing and therapeutically treating a patient for a traumatic brain injury